Chlamydia trachomatis ompA Variants in Trachoma: What Do They Tell Us?
2008

Chlamydia trachomatis Variants in Trachoma

Sample size: 1319 publication 10 minutes Evidence: moderate

Author Information

Author(s): Andreasen Aura A., Burton Matthew J., Holland Martin J., Polley Spencer, Faal Nkoyo, Mabey David C.W., Bailey Robin L.

Primary Institution: London School of Hygiene & Tropical Medicine

Hypothesis

How do different ompA variants of Chlamydia trachomatis affect trachoma infection and treatment outcomes?

Conclusion

Mass treatment significantly reduced the number of Chlamydia trachomatis strains, with one common strain associated with higher infection loads.

Supporting Evidence

  • 7.2% of individuals were infected with Chlamydia trachomatis at baseline.
  • Post-treatment, only three ompA genotypes were present.
  • Most infections detected after treatment were in two villages that experienced mass migration.

Takeaway

This study looked at how different types of bacteria that cause trachoma behave before and after treatment, finding that some types are more common and can cause more severe infections.

Methodology

Samples from a Gambian community were collected before and after mass azithromycin treatment, and analyzed for Chlamydia trachomatis infection and ompA genotypes.

Potential Biases

There may be risks of bias due to the reliance on self-reported travel and infection status.

Limitations

The study may not account for potential clustering of infections by village.

Participant Demographics

Participants were residents of 14 Gambian villages, primarily affected by trachoma.

Statistical Information

P-Value

p<0.0001

Confidence Interval

95% CI 374–90189

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pntd.0000306

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication